Insider Selling: Trupanion, Inc. (NASDAQ:TRUP) COO Sells $102,269.00 in Stock

Trupanion, Inc. (NASDAQ:TRUP) COO John R. Gallagher sold 3,100 shares of the firm’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.99, for a total value of $102,269.00. Following the completion of the transaction, the chief operating officer now owns 25,549 shares in the company, valued at approximately $842,861.51. This trade represents a 10.82 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Trupanion Stock Performance

NASDAQ:TRUP opened at $33.58 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The stock has a 50-day simple moving average of $42.92 and a two-hundred day simple moving average of $47.14. The firm has a market capitalization of $1.43 billion, a PE ratio of -146.00, a P/E/G ratio of 6.02 and a beta of 1.70. Trupanion, Inc. has a 52-week low of $19.69 and a 52-week high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The company had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million. Analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current year.

Hedge Funds Weigh In On Trupanion

Hedge funds have recently modified their holdings of the company. FMR LLC raised its position in shares of Trupanion by 55,963.7% during the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after purchasing an additional 1,170,202 shares during the period. Balyasny Asset Management L.P. raised its holdings in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock valued at $40,548,000 after acquiring an additional 661,559 shares during the period. BNP Paribas Financial Markets lifted its position in shares of Trupanion by 170.7% in the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider’s stock valued at $16,248,000 after acquiring an additional 212,545 shares in the last quarter. Freestone Grove Partners LP purchased a new position in shares of Trupanion in the fourth quarter valued at about $7,776,000. Finally, Baillie Gifford & Co. boosted its stake in shares of Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after acquiring an additional 147,341 shares during the period.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Stifel Nicolaus lowered their target price on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a report on Thursday, February 20th. Piper Sandler lowered their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $46.60.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.